Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Klerfalk Pharma AB

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 1,069 More Arrow 1,139 More Arrow 1,639
Financial expenses 2,968 Less Arrow 537 More Arrow 3,105
Earnings before taxes 171 Less Arrow -343 More Arrow 6,804
EBITDA 74 More Arrow 172 More Arrow 606
Total assets 11,706 Less Arrow 11,636 More Arrow 12,106
Current assets 664 More Arrow 1,215 More Arrow 1,687
Current liabilities 368 More Arrow 469 More Arrow 558
Equity capital 11,228 Less Arrow 11,044 More Arrow 11,438
- share capital 50 Equal arrow 50 Equal arrow 50
Employees (average) 1 Equal arrow 1 Equal arrow 1

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 95.9% Less Arrow 94.9% Less Arrow 94.5%
Turnover per employee 1,069 More Arrow 1,139 More Arrow 1,639
Profit as a percentage of turnover 16.0% Less Arrow -30.1% More Arrow 415.1%
Return on assets (ROA) 26.8% Less Arrow 1.7% More Arrow 81.9%
Current ratio 180.4% More Arrow 259.1% More Arrow 302.3%
Return on equity (ROE) 1.5% Less Arrow -3.1% More Arrow 59.5%
Change turnover -70 Less Arrow -500 More Arrow 522
Change turnover % -6% Less Arrow -31% More Arrow 47%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees % 0% Equal arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.